Wms Partners, LLC Amgen Inc Transaction History

Wms Partners, LLC

$1.7 Billion
Q3 2024

A detailed history of Wms Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wms Partners, LLC holds 1,681 shares of AMGN stock, worth $444,607. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,681

Previous 1,636 2.75%

Holding current value

$444,607

Previous $511,000 5.87%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $13,922 - $15,182	45 Added 2.75%	1,681 $541,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $9,721 - $11,814	-37 Reduced 2.21%	1,636 $511,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $5,377 - $6,491	20 Added 1.21%	1,673 $475,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $1,278 - $1,442	5 Added 0.3%	1,653 $476,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $12,681 - $15,744	-58 Reduced 3.4%	1,648 $442,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $16,713 - $19,762	-78 Reduced 4.37%	1,706 $378,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 1.25%	1,784 $431,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $11,451 - $14,550	50 Added 2.92%	1,762 $462,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $5,162 - $5,822	23 Added 1.36%	1,712 $386,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $2,999 - $3,337	13 Added 0.78%	1,689 $411,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $71,920 - $79,562	328 Added 24.33%	1,676 $405,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $44,151 - $50,527	222 Added 19.72%	1,348 $303,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $2,334 - $2,735	-11 Reduced 0.97%	1,126 $239,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $19,153 - $21,249	-82 Reduced 6.73%	1,137 $277,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $32,842 - $38,272	-148 Reduced 10.83%	1,219 $303,000
Q4 2020 Feb 17, 2021	BUY	$216.38 - $257.67 $23,801 - $28,343	110 Added 8.75%	1,367 $314,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $13,140 - $14,613	56 Added 4.66%	1,257 $319,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $31,345 - $41,572	172 Added 16.72%	1,201 $243,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $18,542 - $23,833	-98 Reduced 8.7%	1,029 $248,000
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $662,140 - $793,381	-3,803 Reduced 77.14%	1,127 $218,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $99,686 - $116,855	-598 Reduced 10.82%	4,930 $909,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $36,174 - $40,776	200 Added 3.75%	5,528 $1.05 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $51,736 - $60,392	-290 Reduced 5.16%	5,328 $1.04 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $7,411 - $8,355	-40 Reduced 0.71%	5,618 $1.17 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $96,309 - $108,175	-580 Reduced 9.3%	5,658 $1.04 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1,181 - $1,320	7 Added 0.11%	6,238 $1.09 Million
Q3 2017 Oct 27, 2017	SELL	$167.29 - $191.0 $14,721 - $16,808	-88 Reduced 1.39%	6,231 $1.16 Million
Q2 2017 Aug 09, 2017	BUY	N/A	6,319	6,319 $1.09 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Account